Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

ETR/RHK stock hub

ETR/RHK has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/RHKis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

816.6M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/RHK

In the news

Latest news · ETR/RHK

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E19.1

P25 12.3P50 15.7P75 20.2

Trailing P/E20.5

P25 16.4P50 20.9P75 30.4

ROE3.1

P25 -6.7P50 8.5P75 17.2

ROIC3.6

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/RHK market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

215

Groups with data

Currency

EUR

Showing 215 of 215 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	DE
Employees	14,144
Employees Change	224%
Employees Change Percent	1.61
Enterprise value	EUR 687.7M
Exchange	Deutsche Börse Xetra
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	DE0007042301
Last refreshed	2026-05-10
Market cap	EUR 816.6M
Price	EUR 12.2
Price currency	EUR
Rev Per Employee	141,623.8x
Sector	Healthcare
Sic	8060
Symbol	etr/RHK
Website	https://www.rhoen-klinikum-ag.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.9%
EV Earnings	17.17x
EV/EBIT	13.25x
EV/EBITDA	6.18x
EV/Sales	0.34x
Forward P/E	19.06x
P/B ratio	0.6x
P/E ratio	20.55x
P/S ratio	0.41x
PE Ratio10 Y	98.01x
PE Ratio3 Y	21.38x
PE Ratio5 Y	30.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.59%
EBITDA Margin	5.38%
Gross margin	10.43%
Gross Profit	EUR 208.9M
Gross Profit Growth	0.06%
Gross Profit Growth Q	14.57%
Gross Profit Growth3 Y	-4.83%
Gross Profit Growth5 Y	2.22%
Net Income	EUR 40.1M
Net Income Growth	0.92%
Net Income Growth Q	78.25%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	9.63%
Net Income Growth5 Y	41.69%
Pretax Margin	2.6%
Profit Margin	2%
Profit Per Employee	EUR 2,832
Profitable Years	24
ROA	1.74
Roa5y	1.35
ROCE	3.49
ROE	3.12
Roe5y	2.81
ROIC	3.57
Roic5y	2.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.82%
Cagr15y	-0.87%
Cagr1y	-15.18%
Cagr20y	-0.45%
Cagr3y	-1.44%
Cagr5y	-4.9%
Div CAGR10	-12.94%
Div CAGR3	10.06%
Div CAGR5	-7.16%
EPS Growth	-0.84
EPS Growth Q	72.73
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	9.53
EPS Growth5 Y	41.61
Revenue Growth	5.87x
Revenue Growth Q	6.75x
Revenue Growth Quarters	9x
Revenue Growth Years	1x
Revenue Growth3 Y	5.82x
Revenue Growth5 Y	5.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.08
Assets	EUR 1.8B
Cash	EUR 160.4M
Current Assets	EUR 915.1M
Current Liabilities	EUR 355.6M
Equity	EUR 1.4B
Interest Coverage	16.86
Liabilities	EUR 476M
Long Term Assets	EUR 925.9M
Long Term Liabilities	EUR 120.5M
Net Cash	EUR 160.4M
Net Cash By Market Cap	EUR 19.65
Net Cash Growth	42.34%
Net Debt EBITDA	EUR -1.49
Net Debt Equity	EUR -0.12
Tangible Book Value	EUR 1.2B
Tangible Book Value Per Share	EUR 17.31
WACC	4.24

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.57
Inventory Turnover	46.69
Net Working Capital	EUR 399.1M
Quick ratio	1.19
Working Capital	EUR 559.6M
Working Capital Turnover	EUR 3.73

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.77%
Dividend Growth	100%
Dividend Growth Years	0%
Dividend per share	EUR 0.2
Dividend Years	2
Dividend Yield	1.64%
Ex Div Date	2026-05-28
Last Dividend	EUR 0.2

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-50.65%
1Y total return	-15.17%
200-day SMA	12.33
3Y total return	-4.25%
50-day SMA	12.59
50-day SMA vs 200-day SMA	50over200
5Y total return	-22.21%
All Time High	54.05
All Time High Change	-77.43%
All Time High Date	2008-04-28
All Time Low	1.09
All Time Low Change	1,024.42%
All Time Low Date	1992-01-06
ATR	0.28
Beta	-0
Beta1y	0
Beta2y	-0.26
Ch YTD	-3.94
High	12.8
High52	14.4
High52 Date	2025-05-08
High52ch	-15.28%
Low	12.2
Low52	11.2
Low52 Date	2025-06-18
Low52ch	8.93%
Ma50ch	-3.07%
Price vs 200-day SMA	-1.06%
RSI	41.97
RSI Monthly	46.66
RSI Weekly	42.95
Sharpe ratio	-0.37x
Sortino ratio	-0.27
Total Return	-0.13%
Tr YTD	-3.94
Tr15y	-12.23%
Tr1m	-1.61%
Tr1w	-3.17%
Tr3m	-6.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 51.8M
Operating Income Growth	14.61
Operating Income Growth Q	92.98
Operating Income Growth3 Y	10.2
Operating Income Growth5 Y	56.81
Operating margin	2.59

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,652,240%
Shares Institutions	0.53%
Shares Out	66,938,470
Shares Qo Q	-0.32%
Shares Yo Y	1.77%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	1,217.1x
Bv Per Share	19.92
Ch10y	-54.57
Ch15y	-26.9
Ch1m	-1.61
Ch1w	-3.17
Ch1y	-15.86
Ch20y	-34.58
Ch3m	-6.15
Ch3y	-6.15
Ch5y	-23.75
Ch6m	2.52
Change	-5.43%
Change From Open	-4.69
Close	12.9
Days Gap	-0.78
Depreciation Amortization	56,025,000
Dollar Volume	14,103.2
Earnings Date	2026-05-07
EBIT	EUR 51.8M
EBITDA	EUR 107.8M
EPS	EUR 0.59
F Score	4
Fiscal Year End	December
Founded	1,973
Graham Number	16.31454
Graham Upside	33.73
Income Tax	EUR 9.9M
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2007-07-13
Last Split Type	Forward
Lynch Fair Value	EUR 14.84
Lynch Upside	21.68
Ma150	12.51
Ma150ch	-2.46%
Ma20	12.41
Ma20ch	-1.65%
Next Earnings Date	2026-08-06
Open	12.8
Payment Date	2026-06-01
Position In Range	0
Ppne	739,830,000
Price Date	2026-05-08
Price EBITDA	EUR 7.57
Ptbv Ratio	0.7
Relative Volume	0.97x
Revenue	2,003,127,000x
Tax By Revenue	0.5x
Tax Rate	19.12%
Tr20y	-8.58%
Tr6m	2.52%
Volume	1,156

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

ETR/RHK dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.6%

$0.20 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-7.2%

0 consecutive years of growth

Total shareholder yield

-0.1%

Next ex-dividend date: 2026-05-28

Performance

ETR/RHK stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/RHK?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.8%

Negative means the company is buying back shares.

Technical

ETR/RHK momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.0

Neutral momentum band

Price vs 200-day MA

-1.1%

50/200-day relationship not available

Beta (5Y)

-0.00

Less volatile than the market

Sharpe ratio

-0.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/RHK

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/RHK stock rating?

etr/RHK is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/RHK analysis?

The full report lives at /stocks/etr/RHK/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/RHK?

The latest report frames etr/RHK around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/RHK page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.